Neurochemical Research

, Volume 38, Issue 10, pp 2105–2113 | Cite as

The Fruits of Maclura pomifera Extracts Inhibits Glioma Stem-Like Cell Growth and Invasion

  • Dan Zhao
  • Chengyun Yao
  • Xiaobing ChenEmail author
  • Hongping XiaEmail author
  • Li Zhang
  • Huixiang Liu
  • Xiaochun Jiang
  • Yi Dai
  • Jun Liu
Original Paper


Glioma is the most common primary intracranial tumour. Recently, growing evidence showed that glioma possesses stem-like cells, which are thought to be chemo- and radio-resistant and believed to contribute to the poor clinical outcomes of these tumours. In this study, we found that stem-like glioma cells (CD133+) were significantly increased in neurosphere cells, which are highly invasive and resistant to multiple chemotherapeutic agents. From our natural products library, we screened 48 natural products and found one compound, Pomiferin, which was of particular interest. Our results showed that Pomiferin could inhibit cell viability, CD133+ cell population, sphere formation, and invasion ability of glioma neurosphere cells. We also found that multiple stemness-associated genes (BIM1, Nestin, and Nanog) were down-regulated by Pomiferin treatment of glioma neurosphere cells. Taken together, our results suggest that Pomiferin could kill the cancer stem-like cells in glioma and may serve as a potential therapeutic agent in the future.


Glioma Stem cell CD133 Natural product Pomiferin 



This study was supported by Grants from the National Natural Science Foundation of China; Grant Number: 81201994.

Conflict of interest



  1. 1.
    Davis FG, McCarthy BJ (2001) Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther 1:395–401PubMedCrossRefGoogle Scholar
  2. 2.
    Benedetti S, Pirola B, Pollo B et al (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6:447–450PubMedCrossRefGoogle Scholar
  3. 3.
    Xia H, Qi Y, Ng SS et al (2009) MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun 380:205–210PubMedCrossRefGoogle Scholar
  4. 4.
    Eby NL, Grufferman S, Flannelly CM et al (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461–2465PubMedCrossRefGoogle Scholar
  5. 5.
    Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253–1261PubMedCrossRefGoogle Scholar
  6. 6.
    Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828PubMedGoogle Scholar
  7. 7.
    Dontu G, Abdallah WM, Foley JM et al (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17:1253–1270PubMedCrossRefGoogle Scholar
  8. 8.
    Diehn M, Clarke MF (2006) Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 98:1755–1757PubMedCrossRefGoogle Scholar
  9. 9.
    Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760PubMedCrossRefGoogle Scholar
  10. 10.
    Gupta PB, Onder TT, Jiang G et al (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645–659PubMedCrossRefGoogle Scholar
  11. 11.
    Galli R, Binda E, Orfanelli U et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011–7021PubMedCrossRefGoogle Scholar
  12. 12.
    Zobalova R, Stantic M, Stapelberg M et al. (2011) Drugs that kill cancer stem-like cells. Cancer stem cells theories and practice. InTech, pp. 361–378Google Scholar
  13. 13.
    Burnett J, Newman B, Sun D (2012) Targeting cancer stem cells with natural products. Curr Drug Targets 13:1054–1064PubMedCrossRefGoogle Scholar
  14. 14.
    Yang R, Hanwell H, Zhang J et al (2011) Antiproliferative activity of Pomiferin in normal (MCF-10A) and transformed (MCF-7) breast epithelial cells. J Agric Food Chem 59:13328–13336PubMedCrossRefGoogle Scholar
  15. 15.
    Abdouh M, Facchino S, Chatoo W et al (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884–8896PubMedCrossRefGoogle Scholar
  16. 16.
    Hart AH, Hartley L, Parker K et al (2005) The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104:2092–2098PubMedCrossRefGoogle Scholar
  17. 17.
    Wagner N, Wagner KD, Scholz H et al (2006) Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms’ tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol 291:R779–R787PubMedCrossRefGoogle Scholar
  18. 18.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 25:402–408PubMedCrossRefGoogle Scholar
  19. 19.
    Clarke MF, Dick JE, Dirks PB et al (2006) Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339–9344PubMedCrossRefGoogle Scholar
  20. 20.
    Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645–648PubMedCrossRefGoogle Scholar
  21. 21.
    Fan X, Khaki L, Zhu TS et al (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28:5–16PubMedGoogle Scholar
  22. 22.
    Bar EE, Chaudhry A, Lin A et al (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25:2524–2533PubMedCrossRefGoogle Scholar
  23. 23.
    Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477PubMedCrossRefGoogle Scholar
  24. 24.
    Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25:475–516PubMedCrossRefGoogle Scholar
  25. 25.
    Laks DR, Masterman-Smith M, Visnyei K et al (2009) Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27:980–987PubMedCrossRefGoogle Scholar
  26. 26.
    Strojnik T, Røsland GV, Sakariassen PO et al (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68:133–143PubMedCrossRefGoogle Scholar
  27. 27.
    Zbinden M, Duquet A, Lorente-Trigos A et al (2010) NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 29:2659–2674PubMedCrossRefGoogle Scholar
  28. 28.
    Son IH, Chung I-M, Lee SI et al (2007) Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera. Bioorg Med Chem Lett 17:4753–4755PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Dan Zhao
    • 1
  • Chengyun Yao
    • 2
  • Xiaobing Chen
    • 3
    Email author
  • Hongping Xia
    • 4
    Email author
  • Li Zhang
    • 1
  • Huixiang Liu
    • 1
  • Xiaochun Jiang
    • 4
  • Yi Dai
    • 4
  • Jun Liu
    • 5
  1. 1.Department of Neurosurgery, Zhangjiagang HospitalSuzhou UniversityZhangjiagangChina
  2. 2.Department of RadiationJiangsu Cancer HospitalNanjingChina
  3. 3.Department of OncologyThe Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhouChina
  4. 4.Department of Surgery, Yijishan HospitalWannan Medical CollegeWuhuChina
  5. 5.Department of Neurosurgery, Ma’an Shan Central HospitalWannan Medical CollegeMa’an ShanChina

Personalised recommendations